Medikinet Retard Capsule 30mg (Methylphenidate Hydrochloride)

Adult dose

The dose of this medicine should be individualized according to the patient's response and tolerability. This medicine should be administered with a meal or immediately after a meal. If a patient taking another formulation of methylphenidate hydrochloride is switched to this medicine, it must be administered immediately after a meal. Take this medicine, or its contents, intact with water. Do not chew or crush the contents of this medicine. ○ Adults Administer this medicine 2 times a day (morning and noon), immediately after meals. The initial dose is 5mg per dose, administered 2 times a day (morning and noon). Increase the daily dose by 10mg each week according to the patient's treatment response and tolerability. The maximum daily dose of this medicine is 1mg/kg and must not exceed 80mg a day. Adult patients who have been continuously taking this medicine since childhood or adolescence should continue taking the same dose they are currently taking. The safety and efficacy of this medicine for long-term administration for more than 6 months have not been studied. When prescribing this medicine long term to patients with ADHD, periodically reassess its efficacy for long-term use by temporarily interrupting drug treatment and conducting a trial to evaluate the patient's social functioning. If symptoms worsen or other adverse reactions occur, reduce the dose and, if necessary, discontinue this medicine. If symptoms do not improve within one month after adjustment to an appropriate dose, discontinue this medicine.

Child dose

○ Children and adolescents aged 6 years and older Administer this medicine once a day, immediately after breakfast. The initial dose is 5mg per dose, administered once a day (in the morning) or 2 times a day (morning and noon). Increase the daily dose by 5 ~ 10mg each week according to the patient's treatment response and tolerability. The maximum daily dose of this medicine is 60mg.

This medication should not be used in individuals with heart problems or cardiovascular diseases. Special caution is needed in children and adolescents with structural heart anomalies or heart rhythm abnormalities due to the risk of sudden death. Patients with hypertension or unstable heart condition should regularly monitor blood pressure and heart rate while using this medication. If sudden chest pain or fainting occurs while on medication, immediate medical attention should be sought. Patients with psychiatric issues may experience worsening symptoms while taking this medication, thus they should be carefully monitored. In particular, if there is a history of psychosis or bipolar disorder, a thorough evaluation of mental state should be done before administering this medication. There is a potential risk of growth suppression with long-term use in children, so their height and weight changes should be closely monitored, and medication may be temporarily discontinued if any growth abnormalities are observed. Patients with a history of seizures or abnormal EEG should be cautious with this medication as it may provoke seizures, and if seizures occur, the medication should be discontinued immediately. Visual side effects such as vision disturbances or eye control abnormalities have been rarely reported, so consultation with a doctor should be sought if vision changes occur. Children under 5 years old should avoid this medication as its safety and efficacy have not been established. Because there is a risk of drug abuse, it is important to take the precise dosage according to a doctor's instructions and avoid adjusting the dosage on one's own. In rare cases, persistent painful erections may occur, and if this symptom arises, immediate notification to medical personnel is necessary. Symptoms of peripheral vascular disease, such as numbness or coldness in the hands and feet, may occur, so if these symptoms persist, consultation with a doctor is advised. This medication should not be given to patients with specific diseases or conditions, particularly patients with severe anxiety, tension, glaucoma, Tourette syndrome, or those taking MAO inhibitors should not use it. Before taking the medication, it is essential to inform the doctor of the current health status and any other medications being taken, and to regularly monitor blood pressure, heart rate, mental status, and growth rate. It is recommended to take this medication with meals or after meals, and capsules should be swallowed whole or the contents may be sprinkled onto applesauce for immediate consumption, but should not be mixed ahead of time. Dizziness may occur while taking this medication, so caution is advised when driving or performing hazardous tasks. This medication should be stored out of reach of children, in its original container, away from direct sunlight and moisture.

• Headache
• diarrhea
• appendicitis
• abdominal pain
• loss of appetite
• insomnia
• nasopharyngitis
• restlessness
• nausea
• palpitations

This medication should be stored in a tightly closed container to protect from air and moisture, at a temperature between 1 and 30 degrees Celsius. Proper storage will safely maintain the efficacy of the medication.

Appearance

A hard capsule with a dark purple upper part and a light gray lower part containing fast-acting white pellets and enteric-coated blue pellets.

Package unit

30 capsules (10 capsules/PTP x 3)